A drug-resistant fungus called Candida auris “is quietly spreading across the globe,” reports the New York Times: Over the last five years, it has hit a neonatal unit in Venezuela, swept through a hospital in Spain, forced a prestigious British medical center to shut down its intensive care unit, and taken root in India, Pakistan and South Africa. Recently C. auris reached New York , New Jersey and Illinois, leading the federal Centers for Disease Control and Prevention (CDC) to add it to a list of germs deemed "urgent threats…"
In the United States, two million people contract resistant infections annually, and 23,000 die from them, according to the official CDC estimate. That number was based on 2010 figures; more recent estimates from researchers at Washington University School of Medicine put the death toll at 162,000. Worldwide fatalities from resistant infections are estimated at 700,000… With bacteria and fungi alike, hospitals and local governments are reluctant to disclose outbreaks for fear of being seen as infection hubs.
Even the CDC, under its agreement with states, is not allowed to make public the location or name of hospitals involved in outbreaks. State governments have in many cases declined to publicly share information beyond acknowledging that they have had cases… [A] hushed panic is playing out in hospitals around the world. Individual institutions and national, state and local governments have been reluctant to publicize outbreaks of resistant infections, arguing there is no point in scaring patients – or prospective ones.
The Times reports that C. auris targets people with weakened immune systems (including babies and the elderly) – and that 587 cases of C. auris have already been reported in the U.S., according to the CDC: 309 cases in New York, 104 in New Jersey, and 144 in Illinois. The CDC adds that half the patients who contract C. auris die within 90 days.
It also survived in a room treated for an entire week with aerosolized hydrogen peroxide, according to the Times. “Simply put, fungi, just like bacteria, are evolving defenses to survive modern medicines.”
The New York Post adds that “Given the speed at which the inspection spreads, coupled with its resistance to medication, ‘the prospect of an endemic or epidemic multidrug-resistant yeast in U.S. healthcare facilities is troubling,’ the CDC said in October.”